特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
236772

医薬品受託製造の世界市場

Pharmaceutical Contract Manufacturing

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 295 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

医薬品受託製造の世界市場
出版日: 2020年07月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 295 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の医薬品受託製造市場について調査し、市場の概要と見通し、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • 医薬品受託製造:概要
    • 現在および将来分析
    • 市場規模
    • 医薬品受託製造サービスは欧米がリード
    • 固定用量がCMO内で今なお人気
    • 注射型製剤がPCM市場の成長を牽引
    • PMC市場の機会
    • 市場促進因子
    • 明るい将来を実現するためには大きな変革が必要
  • 市場動向と促進因子
  • 競合環境
  • サービス概要
    • イントロダクション
    • 注射型薬剤
    • 固定用量製剤
    • 液状製剤
    • 医薬品受託製造の増加
    • 投資リスク
    • 品質保証リスク
    • 薬剤開発リスク
    • 買収リスク
    • クライアント依存リスク
  • 近年の業界活動
  • 主要参入企業
    • Aenova Group
    • Ajinomoto Althea, Inc.
    • Albany Molecular Research Inc.
    • Alcami Corporation
    • Baxter International, Inc.
    • Boehringer Ingelheim GmbH
    • Catalent Pharma Solutions, Inc.
    • Cobra Biologics Holding AB
    • CordenPharma International
    • Dishman Group
    • DPx Holdings B.V.
    • Fareva Group
    • Famar Health Care Services
    • Hospira, Inc.
    • Jubilant Life Sciences Limited
    • Kemwell Biopharma Pvt. Ltd.
    • Lonza Group Ltd.
    • LTS Lohmann Therapie-Systeme AG
    • NextPharma Technologies Holding Ltd.
    • ニプロファーマ株式会社
    • Recipharm AB
  • 世界市場見通し

第3章 市場

  • 米国
  • 日本
  • 欧州
  • アジア太平洋地域
  • その他
目次
Product Code: MCP-1535

Global Pharmaceutical Contract Manufacturing Market to Reach $141 Billion by 2027

Amid the COVID-19 crisis, the global market for Pharmaceutical Contract Manufacturing estimated at US$106.8 Billion in the year 2020, is projected to reach a revised size of US$141 Billion by 2027, growing at a CAGR of 4% over the analysis period 2020-2027. API, one of the segments analyzed in the report, is projected to record a 5.2% CAGR and reach US$51.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the FDF segment is readjusted to a revised 4.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $31.5 Billion, While China is Forecast to Grow at 3.7% CAGR

The Pharmaceutical Contract Manufacturing market in the U.S. is estimated at US$31.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$24.9 Billion by the year 2027 trailing a CAGR of 3.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Advanced Drug Delivery Products Segment to Record 3.5% CAGR

In the global Advanced Drug Delivery Products segment, USA, Canada, Japan, China and Europe will drive the 3.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$15.4 Billion in the year 2020 will reach a projected size of US$19.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$16.1 Billion by the year 2027.We bring years of research experience to this 18th edition of our report. The 295-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Aenova Group
  • Ajinomoto Althea, Inc.
  • Albany Molecular Research Inc.
  • Alcami Corporation
  • Baxter International, Inc.
  • Boehringer Ingelheim GmbH
  • Catalent Pharma Solutions, Inc.
  • Cobra Biologics Holding AB
  • CordenPharma International
  • Dishman Group
  • Famar Health Care Services
  • Hospira, Inc.
  • Jubilant Life Sciences Limited
  • Kemwell Biopharma Pvt. Ltd.
  • Lonza Group Ltd.
  • LTS Lohmann Therapie-Systeme AG
  • NextPharma Technologies Holding Ltd.
  • Nipro Pharma Corporation
  • Recipharm AB
  • Vetter Pharma International GmbH

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Pharmaceutical Contract Manufacturing - A Prelude
  • Recent Market Activity
  • Current & Future Market Outlook
  • Sizing the Market
  • West Leads in PCM Services
  • Solid Dosage Remains Popular Among CMOs
  • Injectable-Dose Formulations to Spearhead Growth of the PCM Market
  • Opportunities Rife for PCM Growth
  • Key Market Drivers
  • Major Changes Imperative to Capitalize on Brighter Future Prospects
  • Global Competitor Market Shares
  • Pharmaceutical Contract Manufacturing Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • Aenova Group (Germany)
  • Ajinomoto Althea, Inc. (USA)
  • Albany Molecular Research Inc. (USA)
  • Alcami Corporation (USA)
  • Baxter International, Inc. (USA)
  • Boehringer Ingelheim GmbH (Germany)
  • Catalent Pharma Solutions, Inc. (USA)
  • Cobra Biologics Holding AB (Sweden)
  • CordenPharma International (Germany)
  • Dishman Group (India)
  • DPx Holdings B.V. (USA)
  • Fareva Group (Luxembourg)
  • Famar Health Care Services (Greece)
  • Hospira, Inc. (USA)
  • Jubilant Life Sciences Limited (India)
  • Kemwell Biopharma Pvt. Ltd. (India)
  • Lonza Group Ltd. (Switzerland)
  • LTS Lohmann Therapie-Systeme AG (Germany)
  • NextPharma Technologies Holding Ltd. (UK)
  • Nipro Pharma Corporation (Japan)
  • Recipharm AB (Sweden)
  • Vetter Pharma International GmbH (Germany)

3. MARKET TRENDS & DRIVERS

  • Changing Face of the CMO Industry
  • Relevance of CMOs Increases in the Modern Pharma Industry
  • Patent Expiries Augur Good Tidings for the PCM Market
  • PCMs Gear Up to Tap Booming Biologics Market
  • Biotechnology Start-Ups Spur Demand for Contract Manufacturing
  • Service Differentiation - The Key to Future Success in Solid Dosage Formulations Manufacturing
  • Strong Growth in Injectables Market to Resonate in Contract Manufacturing
  • Developed Markets Dominate Sterile Injectables Contract Manufacturing Market
  • PCM Market for Vaccines Yet to Take Off
  • PCM Industry Gravitates Eastward, and Subsequently Leads to Near-Shoring
  • Smaller Production Batches are Here to Stay; Compel Facility Efficiency Improvements
  • Upstream Movement Becomes a Compulsion for Many
  • Need to Focus on Better Customer Services Emerges
  • Rising Drug Complexity Presses for Specialized Expertise
  • Adoption of Cutting-Edge Technologies to Radicalize PCM Environment
  • RABS technology
  • Quality by Design
  • Track & Trace Techniques
  • Disposable Processing Techniques
  • Upstream & Downstream Processes
  • Process Analytical Technology
  • Near Infrared Spectroscopy
  • Perfusion Technology Takes Center-stage as Quality and Cost Concerns Rise
  • Downstream Processes Get a Lift as CMOs Seek Ways to Improve Capacity
  • Biopharma Contract Manufacturing Surges Ahead
  • Cost and Risk Containment Objectives Spur Outsourcing of Biopharma Production
  • Contract Manufacturing of ADCs Continues to Rise
  • Competition to Surge in Biological Contract Manufacturing Market
  • CMOs Gear Up for Capacity Expansions to Address Growing Demand from Biopharma
  • Ballooning Global Population Offers Increased Growth Opportunities
  • Aging Population Boosts Opportunities for PCM
  • Increasing Healthcare Expenditure to Spur Demand for Contract Manufacturing of Generics
  • Surge in Generic Drugs to Benefit Pharmaceutical Contract Manufacturers
  • Insourcing of Manufacturing Operations - An Emerging Threat to PCM
  • Vendor Switching- A Growing Concern for PCMs
  • New Challenges Threaten Prospects for CMOs
  • New Distribution Regulations Incites Changes in Operations

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Pharmaceutical Contract Manufacturing Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Pharmaceutical Contract Manufacturing Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Pharmaceutical Contract Manufacturing Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: API (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: API (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: API (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: FDF (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: FDF (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: FDF (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Advanced Drug Delivery Products (Product Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Advanced Drug Delivery Products (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Advanced Drug Delivery Products (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: OTC Medicines & Nutritional Products (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: OTC Medicines & Nutritional Products (Product Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: OTC Medicines & Nutritional Products (Product Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Other Product Types (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 17: Other Product Types (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 18: Other Product Types (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Pharmaceutical (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 20: Pharmaceutical (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
  • TABLE 21: Pharmaceutical (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 22: Biopharmaceutical (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 23: Biopharmaceutical (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 24: Biopharmaceutical (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Sterile (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 26: Sterile (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
  • TABLE 27: Sterile (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
  • TABLE 28: Non-Sterile (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 29: Non-Sterile (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 30: Non-Sterile (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Pharmaceutical Contract Manufacturing Market Share (in %) by Company: 2018 & 2025
    • Market Analytics
    • TABLE 31: United States Pharmaceutical Contract Manufacturing Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 32: Pharmaceutical Contract Manufacturing Market in the United States by Product Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 33: United States Pharmaceutical Contract Manufacturing Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 34: United States Pharmaceutical Contract Manufacturing Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
    • TABLE 35: Pharmaceutical Contract Manufacturing Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
    • TABLE 36: Pharmaceutical Contract Manufacturing Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
    • TABLE 37: United States Pharmaceutical Contract Manufacturing Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 38: Pharmaceutical Contract Manufacturing Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
    • TABLE 39: Pharmaceutical Contract Manufacturing Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 40: Canadian Pharmaceutical Contract Manufacturing Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 41: Canadian Pharmaceutical Contract Manufacturing Historic Market Review by Product Type in US$ Million: 2012-2019
    • TABLE 42: Pharmaceutical Contract Manufacturing Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
    • TABLE 43: Canadian Pharmaceutical Contract Manufacturing Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 44: Pharmaceutical Contract Manufacturing Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
    • TABLE 45: Canadian Pharmaceutical Contract Manufacturing Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 46: Canadian Pharmaceutical Contract Manufacturing Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 47: Pharmaceutical Contract Manufacturing Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 48: Canadian Pharmaceutical Contract Manufacturing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 49: Japanese Market for Pharmaceutical Contract Manufacturing: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 50: Pharmaceutical Contract Manufacturing Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 51: Japanese Pharmaceutical Contract Manufacturing Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 52: Japanese Demand Estimates and Forecasts for Pharmaceutical Contract Manufacturing in US$ Million by Application: 2020 to 2027
    • TABLE 53: Japanese Pharmaceutical Contract Manufacturing Market in US$ Million by Application: 2012-2019
    • TABLE 54: Pharmaceutical Contract Manufacturing Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
    • TABLE 55: Japanese Demand Estimates and Forecasts for Pharmaceutical Contract Manufacturing in US$ Million by End-Use: 2020 to 2027
    • TABLE 56: Japanese Pharmaceutical Contract Manufacturing Market in US$ Million by End-Use: 2012-2019
    • TABLE 57: Pharmaceutical Contract Manufacturing Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 58: Chinese Pharmaceutical Contract Manufacturing Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 59: Pharmaceutical Contract Manufacturing Historic Market Analysis in China in US$ Million by Product Type: 2012-2019
    • TABLE 60: Chinese Pharmaceutical Contract Manufacturing Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 61: Chinese Demand for Pharmaceutical Contract Manufacturing in US$ Million by Application: 2020 to 2027
    • TABLE 62: Pharmaceutical Contract Manufacturing Market Review in China in US$ Million by Application: 2012-2019
    • TABLE 63: Chinese Pharmaceutical Contract Manufacturing Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 64: Chinese Demand for Pharmaceutical Contract Manufacturing in US$ Million by End-Use: 2020 to 2027
    • TABLE 65: Pharmaceutical Contract Manufacturing Market Review in China in US$ Million by End-Use: 2012-2019
    • TABLE 66: Chinese Pharmaceutical Contract Manufacturing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Pharmaceutical Contract Manufacturing Market: Competitor Market Share Scenario (in %) for 2018 & 2025
    • Market Analytics
    • TABLE 67: European Pharmaceutical Contract Manufacturing Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 68: Pharmaceutical Contract Manufacturing Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 69: European Pharmaceutical Contract Manufacturing Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 70: European Pharmaceutical Contract Manufacturing Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 71: Pharmaceutical Contract Manufacturing Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 72: European Pharmaceutical Contract Manufacturing Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 73: European Pharmaceutical Contract Manufacturing Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 74: Pharmaceutical Contract Manufacturing Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
    • TABLE 75: European Pharmaceutical Contract Manufacturing Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 76: European Pharmaceutical Contract Manufacturing Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 77: Pharmaceutical Contract Manufacturing Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 78: European Pharmaceutical Contract Manufacturing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 79: Pharmaceutical Contract Manufacturing Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 80: French Pharmaceutical Contract Manufacturing Historic Market Scenario in US$ Million by Product Type: 2012-2019
    • TABLE 81: French Pharmaceutical Contract Manufacturing Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 82: Pharmaceutical Contract Manufacturing Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
    • TABLE 83: French Pharmaceutical Contract Manufacturing Historic Market Review in US$ Million by Application: 2012-2019
    • TABLE 84: French Pharmaceutical Contract Manufacturing Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
    • TABLE 85: Pharmaceutical Contract Manufacturing Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
    • TABLE 86: French Pharmaceutical Contract Manufacturing Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 87: French Pharmaceutical Contract Manufacturing Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • GERMANY
    • TABLE 88: Pharmaceutical Contract Manufacturing Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 89: German Pharmaceutical Contract Manufacturing Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 90: German Pharmaceutical Contract Manufacturing Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 91: Pharmaceutical Contract Manufacturing Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
    • TABLE 92: German Pharmaceutical Contract Manufacturing Market in Retrospect in US$ Million by Application: 2012-2019
    • TABLE 93: Pharmaceutical Contract Manufacturing Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
    • TABLE 94: Pharmaceutical Contract Manufacturing Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 95: German Pharmaceutical Contract Manufacturing Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 96: Pharmaceutical Contract Manufacturing Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 97: Italian Pharmaceutical Contract Manufacturing Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 98: Pharmaceutical Contract Manufacturing Historic Market Analysis in Italy in US$ Million by Product Type: 2012-2019
    • TABLE 99: Italian Pharmaceutical Contract Manufacturing Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 100: Italian Demand for Pharmaceutical Contract Manufacturing in US$ Million by Application: 2020 to 2027
    • TABLE 101: Pharmaceutical Contract Manufacturing Market Review in Italy in US$ Million by Application: 2012-2019
    • TABLE 102: Italian Pharmaceutical Contract Manufacturing Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 103: Italian Demand for Pharmaceutical Contract Manufacturing in US$ Million by End-Use: 2020 to 2027
    • TABLE 104: Pharmaceutical Contract Manufacturing Market Review in Italy in US$ Million by End-Use: 2012-2019
    • TABLE 105: Italian Pharmaceutical Contract Manufacturing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 106: United Kingdom Market for Pharmaceutical Contract Manufacturing: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 107: Pharmaceutical Contract Manufacturing Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 108: United Kingdom Pharmaceutical Contract Manufacturing Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 109: United Kingdom Demand Estimates and Forecasts for Pharmaceutical Contract Manufacturing in US$ Million by Application: 2020 to 2027
    • TABLE 110: United Kingdom Pharmaceutical Contract Manufacturing Market in US$ Million by Application: 2012-2019
    • TABLE 111: Pharmaceutical Contract Manufacturing Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
    • TABLE 112: United Kingdom Demand Estimates and Forecasts for Pharmaceutical Contract Manufacturing in US$ Million by End-Use: 2020 to 2027
    • TABLE 113: United Kingdom Pharmaceutical Contract Manufacturing Market in US$ Million by End-Use: 2012-2019
    • TABLE 114: Pharmaceutical Contract Manufacturing Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 115: Rest of Europe Pharmaceutical Contract Manufacturing Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 116: Pharmaceutical Contract Manufacturing Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 117: Rest of Europe Pharmaceutical Contract Manufacturing Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 118: Rest of Europe Pharmaceutical Contract Manufacturing Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 119: Pharmaceutical Contract Manufacturing Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
    • TABLE 120: Rest of Europe Pharmaceutical Contract Manufacturing Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 121: Rest of Europe Pharmaceutical Contract Manufacturing Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 122: Pharmaceutical Contract Manufacturing Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 123: Rest of Europe Pharmaceutical Contract Manufacturing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 124: Pharmaceutical Contract Manufacturing Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 125: Asia-Pacific Pharmaceutical Contract Manufacturing Historic Market Scenario in US$ Million by Product Type: 2012-2019
    • TABLE 126: Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 127: Pharmaceutical Contract Manufacturing Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
    • TABLE 128: Asia-Pacific Pharmaceutical Contract Manufacturing Historic Market Review in US$ Million by Application: 2012-2019
    • TABLE 129: Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
    • TABLE 130: Pharmaceutical Contract Manufacturing Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
    • TABLE 131: Asia-Pacific Pharmaceutical Contract Manufacturing Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 132: Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • REST OF WORLD
    • TABLE 133: Rest of World Pharmaceutical Contract Manufacturing Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 134: Rest of World Pharmaceutical Contract Manufacturing Historic Market Review by Product Type in US$ Million: 2012-2019
    • TABLE 135: Pharmaceutical Contract Manufacturing Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
    • TABLE 136: Rest of World Pharmaceutical Contract Manufacturing Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 137: Pharmaceutical Contract Manufacturing Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
    • TABLE 138: Rest of World Pharmaceutical Contract Manufacturing Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 139: Rest of World Pharmaceutical Contract Manufacturing Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 140: Pharmaceutical Contract Manufacturing Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 141: Rest of World Pharmaceutical Contract Manufacturing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 112
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.